Tag Archives: Cluster

Emgality Approved to Treat Episodic Cluster Headache in Adults – Medical Bag

The Food and Drug Administration (FDA) has approved Emgality (galcanezumab-gnlm; Lilly) for injection for the treatment of episodic cluster headache in adults. The approval was based on the results from a phase 3 double-blind, placebo-controlled trial that included 106 patients diagnosed with episodic cluster headaches. Patients were randomized to receive either once-monthly Emgality 300mg administered… Read More »

VTA-DBS May Reduce Refractory Chronic Cluster Headache Frequency, Intensity – Clinical Pain Advisor

Deep brain stimulation in the ventral tegmental area (VTA-DBS) may effectively reduce the frequency and intensity of refractory chronic cluster headache and alleviate anxiety associated with headaches, according to a study published in Cephalalgia. A total of 18 consecutive patients with cluster headache who underwent VTA-DBS were included in the study. Patients were assessed prior… Read More »

FDA Expands Vagus Nerve Device to Cluster Headache Prevention – MD Magazine

The US Food and Drug Administration (FDA) has expanded the label of non-invasive vagus nerve stimulator product gammaCore, from electroCore, Inc, to include adjunctive use in preventing cluster headaches in adult patients. The device, which was previously approved for the treatment of pain associated with migraines and cluster headaches, is a twice-daily self-administered treatment that provides… Read More »